Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2023-02-14 4:06 pm Purchase | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,459,783 7.3% | 367,474 (+8.98%) | View |
| 2023-02-09 08:14 am Sale | 13G | Caribou Biosciences, Inc. CRBU | FMR LLC | 1,443,046 2.365% | -1,880,238 (-56.58%) | View |
| 2023-02-03 2:18 pm Purchase | 13G | Caribou Biosciences, Inc. CRBU | STATE STREET CORP STT | 3,198,893 5.24% | 3,198,893 (New Position) | View |
| 2023-02-03 12:10 pm Purchase | 13G | Caribou Biosciences, Inc. CRBU | BlackRock Inc. BLK | 4,722,083 7.7% | 4,722,083 (New Position) | View |
| 2022-06-01 5:23 pm Sale | 13G | Caribou Biosciences, Inc. CRBU | DUPONT E I DE NEMOURS & CO DD | 2,058,000 3.39% | -1,093,311 (-34.69%) | View |
| 2022-03-01 4:45 pm Purchase | 13G | Caribou Biosciences, Inc. CRBU | DUPONT E I DE NEMOURS & CO DD | 3,151,311 5.24% | 3,151,311 (New Position) | View |
| 2022-02-14 12:35 pm Unchanged | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,092,309 6.8% | 0 (Unchanged) | View |
| 2022-02-11 1:04 pm Purchase | 13G | Caribou Biosciences, Inc. CRBU | FARALLON CAPITAL MANAGEMENT LLC | 2,963,448 4.9% | 2,963,448 (New Position) | View |
| 2022-02-04 09:00 am Purchase | 13D | Caribou Biosciences, Inc. CRBU | Haurwitz Rachel E. | 3,621,319 6% | 3,621,319 (New Position) | View |
| 2021-08-06 5:04 pm Purchase | 13G | Caribou Biosciences, Inc. CRBU | PFM Health Sciences LP | 4,092,309 7.2% | 4,092,309 (New Position) | View |
| 2021-08-03 5:29 pm Purchase | 13G | Caribou Biosciences, Inc. CRBU | Farallon Capital Partners L.P. | 3,356,969 5.9% | 3,356,969 (New Position) | View |
| 2021-07-29 2:54 pm Purchase | 13G | Caribou Biosciences, Inc. CRBU | FMR LLC | 3,323,284 5.86% | 3,323,284 (New Position) | View |
| 2019-03-25 2:19 pm Sale | 13G | Intellia Therapeutics, Inc. NTLA | Caribou Biosciences Inc. CRBU | 1,807,841 4% | -699,404 (-27.90%) | View |
| 2019-01-16 5:29 pm Sale | 13G | Intellia Therapeutics, Inc. NTLA | Caribou Biosciences Inc. CRBU | 2,507,245 5.8% | -2,037,755 (-44.84%) | View |